Target intelligence / Profile preview

Multiple microbial proteins and lipoproteins

Molecular classification
Other, Protein, Lipoprotein
01

Overview

The term Multiple microbial proteins and lipoproteins refers to a broad and heterogeneous group of molecules derived from bacteria, viruses, fungi, or parasites that serve as essential structural components or functional enzymes. These molecules often function as Pathogen-Associated Molecular Patterns (PAMPs), which are recognized by the host's innate immune system through Pattern Recognition Receptors (PRRs) like Toll-like receptors to initiate an inflammatory response (Janeway & Medzhitov, 2002, Annu Rev Immunol). In a pharmacological context, these proteins and lipoproteins are frequently the targets of antimicrobial agents that disrupt cell wall synthesis or protein translation, and they serve as the primary antigenic components in multi-valent vaccines designed to provide immunity against diverse pathogen strains (Pollard & Bijker, 2021, Nat Rev Immunol). Because this entry describes a collective category rather than a single discrete molecular entity, it is generally considered an imprecise target definition for specific drug-receptor modeling.

Other names
Microbial antigensPathogen-associated molecular patternsPAMPsBacterial lipoproteinsSurface proteins
02

Mechanism of action

Drugs typically target these molecules by inhibiting their synthesis, disrupting their structural role in the microbial cell wall, or by utilizing them as antigens in vaccines to elicit a protective immune response.

03

Biological functions

Immune responseCell adhesionMicrobial metabolismStructural integrity
04

Disease associations

InfectionInflammationSepsis
05

Safety considerations

Antimicrobial resistanceDisruption of commensal microbiomeHypersensitivity reactionsJarisch-Herxheimer reaction
06

Interacting drugs

Amoxicillin

4 more in the full profile.

07

Biomarkers

C-reactive proteinProcalcitoninSpecific microbial DNA/RNAAntigen titers

Beyond the preview

Go deeper on Multiple microbial proteins and lipoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple microbial proteins and lipoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call